Carolina Aguilar is the CEO and Co-Founder of INBRAIN Neuroelectronics, a World Economic Forum Technology Pioneer leading the development of graphene-based brain–computer interfaces to decode the nervous system as the body's OS. With over 20 years of experience in healthcare, including 13 years at Medtronic heading global neuromodulation and diabetes businesses, she has a proven track record in scaling innovation. Under her leadership, INBRAIN has raised over $100M, achieved FDA Breakthrough Device Designation, and delivered the world’s first graphene neural implant to humans in collaboration with world players such as Merck KGaA, Mayo Clinic and Microsoft. Passionate about transforming neurotechnology into life-changing therapies, Carolina is shaping the future of real time precision therapeutics worldwide.